Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Family Medicine
Clinical Trials: Lung Injury
A listing of clinical trials currently looking for volunteers to enroll in Lung Injury studies. Click on the closest city to find more detailed information on a research study in your area.
California
Duarte : City of Hope
IBV Valve System, A Humanitarian Use Device Intended to Control Prolonged Air Leaks
Colorado
Denver : University of Colorado / National Jewish Health
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Kentucky
Lexington : GSK Investigational Site
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Massachusetts
Springfield : Baystate Critical Care Medicine / Tufts University School of Medicine
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Michigan
Ann Arbor : University of Michigan
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Minnesota
Rochester : Mayo Clinic
PICCO Study: Risk Prediction and Early Detection of Perioperative Acute Lung Injury
Rochester : Mayo Clinic
Prospective, Randomized, Blinded, Placebo-controlled, Multi-center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)
Rochester : Mayo Clinic
SCD40L & TXA2: Mechanistic Evaluation of Postoperative Acute Lung Injury
Rochester : Mayo Clinic
Transfusion-Related Acute Lung Injury (TRALI): Incidence and Mechanisms
North Carolina
Durham : GSK Investigational Site
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Winston-Salem : Wakeforest University, School of Medicine
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Ohio
Columbus : Ohio State University Medical Center
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Oregon
Portland : The Oregon Clinic
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Pennsylvania
Philadelphia : GSK Investigational Site
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Philadelphia : University of Pennsylvania Medical Center
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Philadelphia : GSK Investigational Site
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Pittsburgh : GSK Investigational Site
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Pittsburgh : University of Pittsburgh Medical Center
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
Tennessee
Nashville : GSK Investigational Site
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
Vermont
Burlington : University of Vermont College of Medicine
Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
United Kingdom
Harrow : GSK Investigational Site
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
